Postoperative Radiotherapy for Non-Small Cell Lung Carcinoma

  • Jeffrey C. Haynes
  • Mitchell Machtay
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)


Radiat Oncol Biol Phys Postoperative Radiotherapy Sublobar Resection Chest Wall Invasion Lung Cancer Study Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albain KS et al (1997) Concurrent cisplatin/etoposide plus radiotherapy (PE+RT) for pathologic stage (path TN) IIIB non-small cell lung cancer (NSCLC): a Southwest Oncology Group (SWOG) phase II study (S9019) (abstract no 1600). Proc Am Soc Clin Oncol DenverGoogle Scholar
  2. Albain KS et al (2003) Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): initial results from intergroup trial 0139 (RTOG 93-09) (abstract no 2497). Proc Am Soc Clin Oncol (ASCO) ChicagoGoogle Scholar
  3. Anonymous, Ludwig Lung Cancer Study Group (1987) Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 205:67–71Google Scholar
  4. Bogart J et al (2000) Radiotherapy following thoracoscopic wedge resection of T1 NSCLC in high risk patients: a CALGB and ECOG Phase II trial (abstract no 1907). Proc Am Soc Clin Oncol (ASCO) New OrleansGoogle Scholar
  5. Chen A et al (1999) Intraoperative 125-I brachytherapy for high risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 44:1057–1063CrossRefPubMedGoogle Scholar
  6. Choi NC et al (1980) Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 6:31PubMedGoogle Scholar
  7. Chung CK et al (1982) Evaluation of adjuvant postoperative radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 8:1877–1880PubMedGoogle Scholar
  8. Cuzick J et al (1987) Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71:15–29PubMedGoogle Scholar
  9. Dautzenberg B et al (1995) Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy int he treamtent of resected nonsmall cell lung caricnoma. A randomized trial of 267 patients. GETCB. Cancer 76:779–786PubMedGoogle Scholar
  10. Dautzenberg B et al (1999) A controlled study of postoperative radiotherapy for patients with completely resected nons-mall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 86:265–273CrossRefPubMedGoogle Scholar
  11. Debevec M et al (1996) Post-operative radiotherapy for radically resected N2 non-small cell lung cancer: randomised clinical study 1988-1992. Lung Cancer 14:99–107CrossRefPubMedGoogle Scholar
  12. Emami B et al (1987) Postoperative radiation therapy in the management of lung cancer. Radiology 164:251–253PubMedGoogle Scholar
  13. Emami B et al (2003) The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable NSCLC: an analysis of RTOG data. Lung Cancer 41:207–214CrossRefPubMedGoogle Scholar
  14. Feld R et al (1984) Sites of recurrence in resected Stage I non-small cell lung cancer: a guide for future studies. J Clin Oncol 2:1352–1358PubMedGoogle Scholar
  15. Feng QF et al (2000) A study of postoperative radiotherapy in patients with non-small cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 47:925–929CrossRefPubMedGoogle Scholar
  16. Fultz PJ et al (2002) Detection and diagnosis of nonpalpable supraclavicular lymph nodes in lung cancer at CT and US. Radiology 222:245–252PubMedGoogle Scholar
  17. Gebitekin C et al (1994) Fate of patients with tumour at the bronchial resection margin. J Cardiothorac Surg 8:339–344CrossRefGoogle Scholar
  18. Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy vs. limited resection for T1 N0 non-small cell lung cancer. Ann Thor Surg 60:615–623CrossRefGoogle Scholar
  19. Ginsberg RJ et al (1994) Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 57:1440–1445PubMedGoogle Scholar
  20. Graham MV et al (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 45:323–329CrossRefPubMedGoogle Scholar
  21. Graham MV et al (2003) RTOG 9705, a phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIA non-small cell lung cancer (NSCLC) patients-promising long term survival results. Proc Am Soc Ther Radiol Oncol (ASTRO). Salt Lake City, UT, Int J Radiat Oncol Biol PhysGoogle Scholar
  22. Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949–1955CrossRefPubMedGoogle Scholar
  23. Huang J et al (2003) Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21:555–563PubMedGoogle Scholar
  24. Immerman SC et al (1981) Site of recurrence in patients with stage I and II carcinoma of the lung resected for cure. Ann Thorac Surg 32:23–27PubMedGoogle Scholar
  25. Kaiser LR et al (1989) Significance of extramucosal residual tumor at the bronchial resection margin. Ann Thorac Surg 47:265–269PubMedGoogle Scholar
  26. Keller SM et al (2000) A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer. N Engl J Med 343:1217–1222CrossRefPubMedGoogle Scholar
  27. Kirsh MM et al (1976) Carcinoma of the lung: results of treatment. Ann Thor Surg 21:371–377Google Scholar
  28. Lafitte JJ et al (1996) Post-irradiation for T2 N0 M0 non-small cell carcinoma: a prospective randomized study. Ann Thorac Surg 62:830–834CrossRefPubMedGoogle Scholar
  29. Law MR et al (1982) Value of radiotherapy for tumour on the bronchial stump after resection for bronchial carcinoma. Thorax 37:496–499PubMedGoogle Scholar
  30. LeChevalier T (2003) Results of the randomized international adjuvant lung cancer trial (IALT): cisplatin-based chemtoheray (CT) vs. no CT in 1867 patients with resected non-small cell lung cancer (NSCLC) (abstract no 6). Proc Am Soc Clin Oncol (ASCO) ChicagoGoogle Scholar
  31. Lee W et al (2003) Limited resection for NSCLC: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 75:237–243CrossRefPubMedGoogle Scholar
  32. LeLorier J et al (1997) Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337:536–542CrossRefPubMedGoogle Scholar
  33. Machtay M (2004) Pulmonary complications of anti-cancer treatment. In: Abeloff M (ed) Clinical oncology. Elsevier, PhiladelphiaGoogle Scholar
  34. Machtay M, Kaiser L, Glatstein E (1999) Is meta-analysis really meta-physics? Chest 116:539–542CrossRefPubMedGoogle Scholar
  35. Machtay M et al (1998) The efficacy of postoperative radiotherapy for non-small cell lung carcinoma (NSCLC) resected with positive margins. American Radium Society, MonacoGoogle Scholar
  36. Machtay M et al (2001) Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected NSCLC. J Clin Oncol 19:3912–3917PubMedGoogle Scholar
  37. Marino P, Preatoni A, Cantoni A (1995) Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis. Cancer 76:593–601PubMedGoogle Scholar
  38. Marks LB, Prosnitz LR (2000) Postoperative radiotherapy for lung cancer: the breast cancer story all over again? Int J Radiat Oncol Biol Phys 48:625–627CrossRefPubMedGoogle Scholar
  39. Marks LB et al (1997) Physical and biological predictors of changes in whole lung function following thoracic radiation. Int J Radiat Oncol Biol Phys 39:563CrossRefPubMedGoogle Scholar
  40. Matthews MJ et al (1973) Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. Cancer Chemother Rep 4:63–67Google Scholar
  41. Mayer R et al (1997) Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 12:954–959Google Scholar
  42. McChesney SL et al (1992) Late radiation response of canine mediastinal tissues. Radiother Oncol 23:41–52PubMedGoogle Scholar
  43. Movsas B et al (1995) Pulmonary radiation injury. Chest 111:1061–1076Google Scholar
  44. Overgaard M et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med 337:949–955CrossRefPubMedGoogle Scholar
  45. Pairolero P et al (1984) Post-surgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thor Surg 38:331–338Google Scholar
  46. Patterson GA et al (1982) The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg 34:692–697PubMedGoogle Scholar
  47. Philips P, Rocmans P, VanHoutte P (1993) Postoperative radiotherapy after pneumonectomy: impact of modern treatment facilities. Int J Radiat Oncol Biol Phys 27:525–529PubMedGoogle Scholar
  48. PORT (1998) Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352:257–263Google Scholar
  49. Ragaz J et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956–962CrossRefPubMedGoogle Scholar
  50. Rosell R, Felip E (2001) Predicting response to paclitaxel/carboplatin-based therapy in NSCLC. Semin Oncol 28[Suppl 14]:37–44CrossRefPubMedGoogle Scholar
  51. Rosell R et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153–158PubMedGoogle Scholar
  52. Roth JA, Atkinson EN, Fossella F, Komaki R, Bernadette-Ryan M, Putnam JB Jr, Lee JS, Dhingra H, de Caro L, Chasen M, Hong WK et al (1998) Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21:1–6CrossRefPubMedGoogle Scholar
  53. Sawyer TE (1997) The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 80:1399–1408CrossRefPubMedGoogle Scholar
  54. Stephens RJ et al (1996) The role of post-operative radiotherapy in non-small cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Br J Cancer 74:632–639PubMedGoogle Scholar
  55. Stewart JR et al (1995) Radiation injury to the heart. Int J Radiat Oncol Biol Phys 31:1205–1211CrossRefPubMedGoogle Scholar
  56. Stewart LA (1995) The Non-small cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899–909PubMedGoogle Scholar
  57. Taylor NA et al (2003) Postoperative radiotherapy increases locoregional control of patients with stage IIIA NSCLC treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys 56:616–625CrossRefPubMedGoogle Scholar
  58. Trodella L et al (2002) Adjuvant radiotherapy in NSCLC with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 62:11–19PubMedGoogle Scholar
  59. Van Houtte P, Rocmans P, Smets P (1980) Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6:983–986PubMedGoogle Scholar
  60. Weisenburger TH et al (1986) Effects of post-operative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315:1377–1381PubMedGoogle Scholar
  61. Wurschmidt F et al (1997) Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases. Int J Radiat Oncol Biol Phys 39:553–559CrossRefPubMedGoogle Scholar
  62. Zinzani PL et al (1996) Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. Haemoatologica 81:132–137Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Jeffrey C. Haynes
    • 1
  • Mitchell Machtay
    • 2
  1. 1.Department of Radiation OncologyThe University of Pennsylvania Medical CenterPhiladelphiaUSA
  2. 2.Department of Radiation Oncology, Kimmel Cancer CenterThomas Jefferson University HospitalPhiladelphiaUSA

Personalised recommendations